Sandrine Thouroude
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sandrine Thouroude has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Christian Muchardt
Sorbonne Université, CNRS, Laboratory of Computational, Quantitative and Synthetic Biology, CQSB, Paris, France
1 shared publication - Christophe Rachez
Sorbonne University - CNRS UMR 7238
1 shared publication - Eric Batsché
Sorbonne Université, Institut de Biologie Paris-Seine (IBPS), CNRS Unit B2A, laboratory of Epigenetics and RNA metabolism in human diseases, 75005 Paris, France
1 shared publication - Mickael Costallat
Computational, Quantitative, and Synthetic Biology (CQSB), Centre National de la Recherche Scientifique (CNRS), Sorbonne Université, 75005 Paris, France
1 shared publication - Mikkel Carstensen
Department of Biomedicine, Aarhus University, Aarhus, Denmark
1 shared publication - Thor Petersen
Department of Neurology, Aarhus University Hospital, Denmark
1 shared publication
Latest Publications
- Open Access
- 19 July 2024
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 7 (10) , e202402586
Defective Integrator activity shapes the transcriptome of patients with multiple sclerosis
HP1α/CBX5 is an epigenetic regulator with a suspected role in multiple sclerosis (MS). Here, using high-depth RNA sequencing on monocytes, we identified a subset of MS patients with reduced CBX5 expression, correlating with progressive stages of the disease and extensive transcriptomic alterations. Examination of rare non-coding RNA species in these patients revealed impaired maturation/degradation of U snRNAs and enhancer RNAs, indicative of reduced activity of the Integrator, a complex with suspected links to increased MS risk. At protein-coding genes, compromised Integrator activity manifested in reduced pre-mRNA splicing efficiency and altered expression of genes regulated by RNA polymerase II pause–release. Inactivation of Cbx5 in the mouse mirrored most of these transcriptional defects and resulted in hypersensitivity to experimental autoimmune encephalomyelitis. Collectively, our observations suggested a major contribution of the Integrator complex in safeguarding against transcriptional anomalies characteristic of MS, with HP1α/CBX5 emerging as an unexpected regulator of this complex’s activity. These findings bring novel insights into the transcriptional aspects of MS and provide potential new criteria for patient stratification.
- 19 July 2024
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 7 (10) , e202402586
Open AccessDefective Integrator activity shapes the transcriptome of patients with multiple sclerosis
HP1α/CBX5 is an epigenetic regulator with a suspected role in multiple sclerosis (MS). Here, using high-depth RNA sequencing on monocytes, we identified a subset of MS patients with reduced CBX5 expression, correlating with progressive stages of the disease and extensive transcriptomic alterations. Examination of rare non-coding RNA species in these patients revealed impaired maturation/degradation of U snRNAs and enhancer RNAs, indicative of reduced activity of the Integrator, a complex with suspected links to increased MS risk. At protein-coding genes, compromised Integrator activity manifested in reduced pre-mRNA splicing efficiency and altered expression of genes regulated by RNA polymerase II pause–release. Inactivation of Cbx5 in the mouse mirrored most of these transcriptional defects and resulted in hypersensitivity to experimental autoimmune encephalomyelitis. Collectively, our observations suggested a major contribution of the Integrator complex in safeguarding against transcriptional anomalies characteristic of MS, with HP1α/CBX5 emerging as an unexpected regulator of this complex’s activity. These findings bring novel insights into the transcriptional aspects of MS and provide potential new criteria for patient stratification.